Alterola Biotech, Inc.: 10-Q filed 2014-03-07

Name: Alterola Biotech, Inc.: 10-Q filed 2014-03-07
Creator: Alterola Biotech, Inc.

What Alterola Biotech, Inc. reported in its quarterly report filed 2014-03-07 (fiscal Q3 2012): 21 published measures, 69 facts as tagged in accession 0001255294-14-000150.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-03-07
Fiscal period: fiscal Q3 2012
Accession: 0001255294-14-000150 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Alterola Biotech, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-06-30	6,200	USD
At 2011-09-30	6,200	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-06-30	-110,826	USD
At 2011-09-30	-101,676	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2012-06-30	0	USD
At 2011-09-30	0	USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-10-01 to 2012-06-30	0	USD	274
2008-07-21 to 2012-06-30	-289,376	USD	1441
2010-10-01 to 2011-06-30	-50,028	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-10-01 to 2012-06-30	0	USD	274
2008-07-21 to 2012-06-30	-5,000	USD	1441
2010-10-01 to 2011-06-30	0	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2012-04-01 to 2012-06-30	USD	91
2011-10-01 to 2012-06-30	USD	274
2008-07-21 to 2012-06-30	USD	1441
2011-04-01 to 2011-06-30	USD	91
2010-10-01 to 2011-06-30	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-10-01 to 2012-06-30	0	USD	274
2008-07-21 to 2012-06-30	300,576	USD	1441
2010-10-01 to 2011-06-30	50,000	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-10-01 to 2012-06-30	0	USD	274
2008-07-21 to 2012-06-30	11,200	USD	1441
2010-10-01 to 2011-06-30	0	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-06-30	-321,656	USD
At 2011-09-30	-312,506	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	0	USD	91
2011-10-01 to 2012-06-30	0	USD	274
2008-07-21 to 2012-06-30	26,000	USD	1441
2011-04-01 to 2011-06-30	0	USD	91
2010-10-01 to 2011-06-30	0	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-650	USD	91
2011-10-01 to 2012-06-30	-1,950	USD	274
2008-07-21 to 2012-06-30	-356,195	USD	1441
2011-04-01 to 2011-06-30	-1,000	USD	91
2010-10-01 to 2011-06-30	-53,028	USD	273

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	2,400	USD	91
2011-10-01 to 2012-06-30	7,200	USD	274
2008-07-21 to 2012-06-30	18,890	USD	1441
2011-04-01 to 2011-06-30	2,400	USD	91
2010-10-01 to 2011-06-30	7,200	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-06-30	117,026	USD
At 2011-09-30	107,876	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	650	USD	91
2011-10-01 to 2012-06-30	1,950	USD	274
2008-07-21 to 2012-06-30	356,195	USD	1441
2011-04-01 to 2011-06-30	1,000	USD	91
2010-10-01 to 2011-06-30	53,028	USD	273

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-06-30	132,850	USD
At 2011-09-30	132,850	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2012-06-30	80,000	USD
At 2011-09-30	80,000	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-06-30	18,136	USD
At 2011-09-30	16,186	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2012-06-30	0	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-3,050	USD	91
2011-10-01 to 2012-06-30	-9,150	USD	274
2008-07-21 to 2012-06-30	-373,902	USD	1441
2011-04-01 to 2011-06-30	-3,400	USD	91
2010-10-01 to 2011-06-30	-81,728	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	0	USD	91
2011-10-01 to 2012-06-30	0	USD	274
2008-07-21 to 2012-06-30	12,644	USD	1441
2011-04-01 to 2011-06-30	1,000	USD	91
2010-10-01 to 2011-06-30	3,028	USD	273

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Unit	Days
2012-04-01 to 2012-06-30	USD	91
2011-10-01 to 2012-06-30	USD	274
2008-07-21 to 2012-06-30	USD	1441
2011-04-01 to 2011-06-30	USD	91
2010-10-01 to 2011-06-30	USD	273

Inspect the source

Entity: Alterola Biotech, Inc. / CIK 0001442999
Captured: 2026-09-21T17:19:50.475Z
SEC response SHA-256: 87a3a16f9156f52960516ff7604a147caa80abebfe964591df0bd913491df844

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001442999.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))